Ashley P Davenport, MD

Ashley P Davenport, MD

Physician

4.8 out of 5

Specialty:Medical Oncology

Gender: female

  • I am a medical oncologist who specializes in treating patients with breast cancer. I joined the Division of Medical Oncology at The Ohio State University after the completion of my fellowship training in hematology and oncology at Yale University in New Haven, Conn. I chose the field of breast cancer because of the unparalleled advances that it continues to make in understanding and treating this disease. Ongoing research in genomics, tumor biology and clinical trials provide the promise and framework to deliver personalized treatment for each patient diagnosed with breast cancer. The OSUCCC – James is the optimal environment for patient-centered, guideline-based care thanks to its unparalleled multidisciplinary breast center, robust clinical trial portfolio and expansive support services. The James is not only a leader in breast cancer research, but it also cultivates a collaborative environment dedicated to providing patients with the resources and support they need throughout their treatment. As a member of the Cancer Control Program at the OSUCCC – James, my research is focused on the development of education models to advance the teaching of oncology professionals and improve patient access to quality oncology care. My goal is to utilize technology to improve education for community providers and expand access to quality cancer care to all patients throughout the state of Ohio. To date, my research has focused on developing the Project ECHO platform to train community providers on cancer survivorship best practices. I have also co-authored publications in such peer-reviewed scientific journals as Breast Cancer Research and Treatment and Blood Advances. In addition to my clinical and research work, I am a committed educator with numerous teaching awards and a dedication to advancing continuing education within the field of oncology. I also serve as a faculty member for the American Cancer Society’s Patient Bone Health in Breast and Prostate Cancers ECHO Clinic and as a member of several professional organizations, including the American College of Physicians, the American Society of Clinical Oncology and the American Society of Hematology.

    • Medical Oncology
    • Breast Cancer
  • Stefanie Spielman Comprehensive Breast Center

    Stefanie Spielman Comprehensive Breast Center

    Location Information
  • Medical School

    • Georgetown University School of Medicine
      3900 Nw Reservoir Rd, Washington, DC

    Residency - Internal Medicine

    • McGaw Medical Center of Northwestern University
      420 E Superior St, Chicago, IL

    Fellowship - Hematology & Oncology

    • Yale-New Haven Hospital of St. Raphael
      1450 Chapel St, New Haven, CT
  • Patient Satisfaction Review

    The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

    The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

    4.8 out of 5 overall

    Kept you informed about your condition and treatment
    4.8 / 5
    Amount of time spent with you
    4.8 / 5
    Concern for your questions and issues
    4.9 / 5
    Skill and knowledge
    4.8 / 5
    Overall quality of care
    4.9 / 5

    Patient Comments

    Reviewed on January 12, 2025

    Dr Davenport, very helpful. Took time ask questions. No complaints

    Reviewed on December 25, 2024

    Dr. Davenport, Sarah, NP, and her staff spend as long as I need to understand my condition. They always take time to answer questions. If I forgot to ask one, I can use MyChart and they will get back to me.

    Reviewed on October 27, 2024

    Excellent provider!

    Reviewed on October 20, 2024

    Dr Davenport goes above and beyond. She is not only extremely knowledgeable , but she truly cares for her patients and conveys a warm and trustworthy rapport, adding to the security and comfort of her patients .

    Reviewed on October 15, 2024

    Excellent

    Reviewed on September 8, 2024

    Great experience

    Reviewed on June 5, 2024

    Dr. Davinport listened to my concerns about negative, debilitating side effects and we agreed upon a resolution. She is always willing to take whatever time is necessary to discuss my treatment plan and answer questions and provide suggestions to assist me.

    Reviewed on June 5, 2024

    Asked me a couple of times "What else?" and this was really great in case I forgot something which I often do having had chemo.

    Reviewed on May 19, 2024

    Very informative

    Reviewed on October 31, 2023

    Dr. PARISER is excellent, always enjoy seeing her. She takes her time and is genuinely caring and takes time with me and makes great suggestions for a better health path.

    Reviewed on October 16, 2023

    Was impressed by the knowledge of my new Oncologist with all my info from previous Oncologist in FL. Studied and presented summary well.

    Reviewed on May 2, 2023

    Excellent patient skills

  • August 16, 2023

    Perspectives of patients undergoing neoadjuvant chemotherapy for breast cancer during the COVID-19 pandemic.

    Gaughan AA, MacEwan SR, Rush LJ, Gatti-Mays ME, Pariser AC, McAlearney AS

    Cancer Rep (Hoboken)

    June 24, 2023

    The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.

    Johnson KCC, Goldstein D, Tharakan J, Quiroga D, Kassem M, Grimm M, Miah A, Vargo C, Berger M, Sudheendra P, Pariser A, Gatti-Mays ME, Williams N, Stover D, Sardesai S, Wesolowski R, Ramaswamy B, Tozbikian G, Schnell PM, Cherian MA

    Oncol Ther

    April 1, 2023

    Delivery of Cancer Survivorship Education to Community Healthcare Professionals.

    Pariser AC, Brita J, Harrigan M, Capozza S, Khairallah A, Sanft TB

    J Cancer Educ

    July 10, 2022

    Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies.

    Grimm M, Radcliff L, Giles M, Nash R, Holley E, Panda S, Brophy L, Williams N, Cherian M, Stover D, Gatti-Mays ME, Wesolowski R, Sardesai S, Sudheendra P, Reinbolt R, Ramaswamy B, Pariser A

    J Clin Med

    November 1, 2019

    Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States.

    Pariser AC, Sedghi T, Soulos PR, Killelea B, Gross CP, Mougalian SS

    Breast Cancer Res Treat

  • At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Davenport has reported no relationships with companies or entities.